GB9908190D0 - Diagnosis of lysosomal storage disorders using saposins and other markers - Google Patents

Diagnosis of lysosomal storage disorders using saposins and other markers

Info

Publication number
GB9908190D0
GB9908190D0 GBGB9908190.3A GB9908190A GB9908190D0 GB 9908190 D0 GB9908190 D0 GB 9908190D0 GB 9908190 A GB9908190 A GB 9908190A GB 9908190 D0 GB9908190 D0 GB 9908190D0
Authority
GB
United Kingdom
Prior art keywords
saposins
markers
diagnosis
lysosomal storage
storage disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9908190.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharming Intellectual Property BV
Original Assignee
Pharming Intellectual Property BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharming Intellectual Property BV filed Critical Pharming Intellectual Property BV
Priority to GBGB9908190.3A priority Critical patent/GB9908190D0/en
Publication of GB9908190D0 publication Critical patent/GB9908190D0/en
Priority to NZ514166A priority patent/NZ514166A/en
Priority to KR1020017011737A priority patent/KR20020021775A/ko
Priority to CA002366232A priority patent/CA2366232C/en
Priority to US09/936,957 priority patent/US7378231B1/en
Priority to EP00908836A priority patent/EP1163527B1/en
Priority to PCT/AU2000/000193 priority patent/WO2000055632A1/en
Priority to AT00908836T priority patent/ATE424562T1/de
Priority to KR1020087024543A priority patent/KR20080102423A/ko
Priority to DE60041694T priority patent/DE60041694D1/de
Priority to IL14534500A priority patent/IL145345A0/xx
Priority to JP2000605213A priority patent/JP4703008B2/ja
Priority to AU31357/00A priority patent/AU776842B2/en
Priority to IL145345A priority patent/IL145345A/en
Priority to NZ533214A priority patent/NZ533214A/en
Priority to US10/973,189 priority patent/US7361481B2/en
Priority to JP2010049695A priority patent/JP2010139511A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB9908190.3A 1999-03-17 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers Ceased GB9908190D0 (en)

Priority Applications (17)

Application Number Priority Date Filing Date Title
GBGB9908190.3A GB9908190D0 (en) 1999-04-09 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers
AU31357/00A AU776842B2 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
KR1020087024543A KR20080102423A (ko) 1999-03-17 2000-03-17 사포신 및 기타 마커를 사용하는 리소좀 축적 질환의 진단 방법
IL14534500A IL145345A0 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
CA002366232A CA2366232C (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
US09/936,957 US7378231B1 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
EP00908836A EP1163527B1 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
PCT/AU2000/000193 WO2000055632A1 (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
AT00908836T ATE424562T1 (de) 1999-03-17 2000-03-17 Diagnose von lysosomalen speicherungskrankheiten unter verwendung von saposinen und anderen markern
NZ514166A NZ514166A (en) 1999-03-17 2000-03-17 Diagnosis of lysosomal storage disorders using saposins and other markers
DE60041694T DE60041694D1 (de) 1999-03-17 2000-03-17 Nter verwendung von saposinen und anderen markern
KR1020017011737A KR20020021775A (ko) 1999-03-17 2000-03-17 사포신 및 기타 마커를 사용하는 리소좀 축적 질환의 진단방법
JP2000605213A JP4703008B2 (ja) 1999-03-17 2000-03-17 被験体におけるリソソーム貯蔵障害の診断またはモニターのために少なくとも１つのサポシンのレベルを使用する方法
IL145345A IL145345A (en) 1999-03-17 2001-09-10 Diagnosis of lysosomal storage disorders using saposins and other markers
NZ533214A NZ533214A (en) 1999-03-17 2004-05-28 Diagnosis of lysosomal storage disorders using saposins and other markers
US10/973,189 US7361481B2 (en) 1999-04-09 2004-10-26 Diagnosis of lysosomal storage disorders using saposins and other markers
JP2010049695A JP2010139511A (ja) 1999-03-17 2010-03-05 サポシンおよび他のマーカーを用いるリソソーム貯蔵障害の診断

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9908190.3A GB9908190D0 (en) 1999-04-09 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers

Publications (1)

Publication Number Publication Date
GB9908190D0 true GB9908190D0 (en) 1999-06-02

Family

ID=10851273

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9908190.3A Ceased GB9908190D0 (en) 1999-03-17 1999-04-09 Diagnosis of lysosomal storage disorders using saposins and other markers

Country Status (2)

Country Link
JP (1) JP4703008B2 (enExample)
GB (1) GB9908190D0 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1163527B1 (en) * 1999-03-17 2009-03-04 Women's And Children's Hospital Diagnosis of lysosomal storage disorders using saposins and other markers
JP4833831B2 (ja) * 2003-03-31 2011-12-07 ウイミンズ、アンド、チルドランズ、ホスピトル リソソーム蓄積症（ｌｄｓ）の多重スクリーニング
ES2731920T3 (es) * 2013-05-14 2019-11-19 Centogene Ag Método para el diagnóstico de la enfermedad de Niemann-Pick

Also Published As

Publication number Publication date
JP2002539455A (ja) 2002-11-19
JP4703008B2 (ja) 2011-06-15

Similar Documents

Publication Publication Date Title
HUP0101854A3 (en) The use of fumaric acid derivatives in transplant medicine
HRP20060251B1 (hr) Supstituirani oksazolidinoni i njihova uporaba
EG25931A (en) In6-position substituted indolines the preparationthereof and their use as pharmaceutical compositi ons
IL144214A0 (en) Benzoheterocycles and their use as mek inhibitors
IL148657A0 (en) Stent range transducers and methods of use
IL141403A0 (en) Deleted adenoviruses and methods of making and administering the same
AU7375100A (en) Water absorbent keratin and gel formed therefrom
HUP0202477A3 (en) Use of phthalazine derivatives
EP1024130A4 (en) BIPHENYL-5-ALKANIC ACID DERIVATIVES AND THEIR USE
HUP0200386A3 (en) Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity and pharmaceutical compositions containing them and their use
GB0004167D0 (en) 1-piperidinyl-propan-2-ol derivatives and their use as therapeutic agents
FR2791747B1 (fr) Disque d'accouplement
EP1183030A4 (en) PROCESS FOR THE PREPARATION AND ITS USE OF N-DESMETHYLZOPICLONE
PL335555A1 (en) Novel compounds - substituted benzamides and therapeutic agent
AU4848200A (en) Intravascular device and methods of manufacture and use
GB2367103B (en) Connector and method of use of the connector
EG22491A (en) Rest-breaking composition and use thereof
GB9907965D0 (en) Medical use
AU3774100A (en) Heat-activated cleaning compositions with wrinkle-resistance and methods of use
GB9908190D0 (en) Diagnosis of lysosomal storage disorders using saposins and other markers
PL363048A1 (en) Azabicyclic derivatives and their therapeutic use
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
FR2789137B1 (fr) Disque d'accouplement
HUP0105351A3 (en) Effervescent laxatives and their use
GB9925379D0 (en) Medical use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)